Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancer.
Tajima H, Makino I, Gabata R, Okazaki M, Ohbatake Y, Shimbashi H, Nakanuma S, Saitoh H, Shimada M, Yamaguchi T, Okamoto K, Moriyama H, Kinoshita J, Nakamura K, Miyashita T, Ninomiya I, Fushida S, Ikeda H, Ohta T. Tajima H, et al. Among authors: ohbatake y. Mol Clin Oncol. 2021 Feb;14(2):26. doi: 10.3892/mco.2020.2188. Epub 2020 Dec 14. Mol Clin Oncol. 2021. PMID: 33414907 Free PMC article.
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer.
Tajima H, Ohta T, Shinbashi H, Hirose A, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Miyashita T, Takamura H, Ninomiya I, Fushida S, Nakamura H. Tajima H, et al. Among authors: ohbatake y. Mol Clin Oncol. 2017 May;6(5):753-757. doi: 10.3892/mco.2017.1206. Epub 2017 Mar 30. Mol Clin Oncol. 2017. PMID: 28529750 Free PMC article.
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-paclitaxel Reduces the Number of Cancer-associated Fibroblasts Through Depletion of Pancreatic Stroma.
Miyashita T, Tajima H, Makino I, Okazaki M, Yamaguchi T, Ohbatake Y, Nakanuma S, Hayashi H, Takamura H, Ninomiya I, Fushida S, Kishimoto K, Harmon JW, Ohta T. Miyashita T, et al. Among authors: ohbatake y. Anticancer Res. 2018 Jan;38(1):337-343. doi: 10.21873/anticanres.12227. Anticancer Res. 2018. PMID: 29277792
Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer.
Tajima H, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Terai S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Miyashita T, Takamura H, Ninomiya I, Fushida S, Ohta T. Tajima H, et al. Among authors: ohbatake y. Mol Clin Oncol. 2018 Apr;8(4):623-627. doi: 10.3892/mco.2018.1579. Epub 2018 Feb 20. Mol Clin Oncol. 2018. PMID: 29556385 Free PMC article.
[A Case of Pathological Complete Response Induced by Preoperative Chemotherapy with Gemcitabine plus Nab-Paclitaxel in a Patient with Pancreatic Cancer on Hemodialysis].
Okazaki M, Tajima H, Ohbatake Y, Terai S, Nakanuma S, Okamoto K, Sakai S, Makino I, Kinoshita J, Nakamura K, Miyashita T, Takamura H, Ninomiya I, Fushida S, Ohta T. Okazaki M, et al. Among authors: ohbatake y. Gan To Kagaku Ryoho. 2018 Dec;45(13):2162-2164. Gan To Kagaku Ryoho. 2018. PMID: 30692318 Japanese.
Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer.
Tajima H, Ohta T, Okazaki M, Yamaguchi T, Ohbatake Y, Okamoto K, Nakanuma S, Kinoshita J, Makino I, Nakamura K, Miyashita T, Takamura H, Ninomiya I, Fushida S, Nakamura H. Tajima H, et al. Among authors: ohbatake y. Mol Clin Oncol. 2019 Aug;11(2):157-166. doi: 10.3892/mco.2019.1867. Epub 2019 May 24. Mol Clin Oncol. 2019. PMID: 31281650 Free PMC article.
Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin.
Ohbatake Y, Fushida S, Tsukada T, Kinoshita J, Oyama K, Hayashi H, Miyashita T, Tajima H, Takamura H, Ninomiya I, Yashiro M, Hirakawa K, Ohta T. Ohbatake Y, et al. Clin Exp Med. 2016 Nov;16(4):585-592. doi: 10.1007/s10238-015-0387-9. Epub 2015 Sep 10. Clin Exp Med. 2016. PMID: 26359244 Free PMC article.
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K, Ninomiya I, Ohbatake Y, Hirose A, Tsukada T, Nakanuma S, Sakai S, Kinoshita J, Makino I, Nakamura K, Hayashi H, Oyama K, Inokuchi M, Nakagawara H, Miyashita T, Hidehiro T, Takamura H, Fushida S, Ohta T. Okamoto K, et al. Among authors: ohbatake y. Oncol Rep. 2016 Dec;36(6):3333-3342. doi: 10.3892/or.2016.5133. Epub 2016 Sep 28. Oncol Rep. 2016. PMID: 27748881
32 results